• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Danaher Corp.

Danaher beats The Street in Q1

April 21, 2022 By Sean Whooley

Danaher (NYSE:DHR) shares dipped slightly today on first-quarter results that came in ahead of the consensus forecast. The Washington, D.C.-based company posted profits of $1.7 billion, or $2.31 per share, on sales of $7.7 billion for the three months ended April 1, 2022, for a 1.3% bottom-line gain on sales growth of 12.1%. Adjusted to […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: danaher, Danaher Corp.

Danaher announces executive changes

August 25, 2021 By Sean Whooley

Danaher (NYSE:DHR) has announced a number of personnel moves among executives at the company. SVP & chief accounting officer Robert S. Lutz notified the company that he will step down from his position as of Jan. 1, 2022, with Cristopher M. Bouda set to succeed him, Danaher announced yesterday. Bouda has served as Danaher’s VP […]

Filed Under: Business/Financial News Tagged With: danaher, Danaher Corp., Personnel Moves

Danaher rises on Street-beating Q2

July 22, 2021 By Sean Whooley

Danaher (NYSE:DHR) shares ticked up today on second-quarter results that beat the consensus forecast. The Washington, D.C.–based company posted profits of $1.7 billion, or $2.40 per share, on sales of $7.2 billion for the three months ended July 2, 2021, for a 95.5% bottom-line gain on sales growth of 36.3%. Adjusted to exclude one-time items, […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: danaher, Danaher Corp.

Danaher ticks up on Street-beating Q1

April 22, 2021 By Sean Whooley

Danaher (NYSE:DHR) shares rose before hours on first-quarter results that easily toppled the consensus forecast. The Washington, D.C.-based company posted profits of $1.7 billion, or $2.29 per share, on sales of $6.9 billion for the three months ended April 2, 2021, nearly tripling its bottom-line on sales growth of 57.9%. Adjusted to exclude one-time items, earnings […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: danaher, Danaher Corp.

3M, Abbott in top 50 of Fortune’s most admired companies list

February 1, 2021 By Chris Newmarker

Medtech giants  3M (NYSE:MMM) and Abbott (NYSE:ABT) made it into the top 50 of Fortune‘s 2021 World’s Most Admired Companies list. 3M — a manufacturing conglomerate that also has one of the largest medical device businesses in the world — came in at No. 24, up from No. 29 in the 2020 list. Abbott meanwhile was No. […]

Filed Under: Business/Financial News, Featured Tagged With: 3m, Abbott, Boston Scientific, Danaher Corp., Medtronic, Stryker, Thermo Fisher Scientific

Danaher rises on Street-beating Q4

January 28, 2021 By Sean Whooley

Danaher (NYSE:DHR) shares ticked up this morning on fourth-quarter results that topped the consensus forecast. The Washington, D.C.-based company posted profits of $1.2 billion, or $1.66 per share, on sales of $6.8 billion for the three months ended Dec. 31, 2020, for a -4.8% bottom-line slide on sales growth of 38.9%. Adjusted to exclude one-time items, […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: coronavirus, COVID-19, Danaher Corp.

The 10 largest medical device companies in the world

November 17, 2020 By Chris Newmarker

Even as the world’s largest medical device companies grapple with COVID-19 and the resulting recession, they’re doing important work to help humanity manage the crisis. Read on to find out more about the 10 largest companies in the Big 100, MassDevice and Medical Design & Outsourcing’s annual analysis of the worlds’ 100 largest medical device companies. […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: Big 100, Cardinal Health, danaher, Danaher Corp., EssilorLuxottica, GE Healthcare, Johnson & Johnson, MassDevice Big 100, Medline Industries Inc., Medtronic, Philips, Siemens Healthineers, Stryker

Cepheid wins EUA for COVID-19, flu, RSV combination test

September 29, 2020 By Sean Whooley

Cepheid announced today that it received FDA emergency use authorization for its Xpert Xpress SARS-CoV-2/Flu/RSV diagnostic test. The Danaher Corp. (NYSE:DHR) subsidiary’s rapid molecular diagnostic test for detecting the viruses causing COVID-19, Flu A, Flu B and RSV infections in a single patient can be used in tandem with any of Cepheid’s GeneXpert systems across the […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Cepheid, coronavirus, COVID-19, Danaher Corp., FDA

Danaher down on inline Q1 results

May 7, 2020 By Danielle Kirsh

Danaher posted first-quarter results that were in line with the consensus on Wall Street. The Washington, D.C.-based company reported profits of $595.1 million, or 81¢ per share on sales of $4.3 billion for the three months ended March 31, for a bottom-line gain of 78.3% sales growth of 2.9% compared with Q1 2019. Adjusted to […]

Filed Under: Wall Street Beat Tagged With: Danaher Corp.

Rainer M. Blair to move up to corner office at Danaher

May 6, 2020 By Chris Newmarker

Danaher (NYSE:DHR) announced today that EVP Rainer M. Blair will become CEO after Thomas P. Joyce Jr.’s retirement on Sept. 1. Joyce will stay on as a senior advisor at Danaher through February 28, 2021. “This announced transition comes at a time when Danaher has never been stronger or better positioned to compete given our attractive […]

Filed Under: Business/Financial News, Featured Tagged With: Danaher Corp., Personnel Moves

GE closes $20b sale of BioPharma to Danaher

April 1, 2020 By Sean Whooley

General Electric (NYSE:GE) announced that it completed the sale of its BioPharma business to Danaher (NYSE:DHR) for net proceeds totaling approximately $20 billion. Boston-based GE said in a news release that, under the agreeement, it received a total consideration worth $21.4 billion, with $21 billion in cash along with Danaher’s assumption of certain pension liabilities. After accounting for […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Pharmaceutical Tagged With: Danaher Corp., GE, GE Healthcare, General Electric

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 6
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS